Skip To Main Content
 

Incident and Prevalent counts by quarter

Incident counts of reported ESRD, 2014 Q1 - 2016 Q3
2014^ 2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
0 - 19 302 260 240 289 268 297 271 265 286 265 268
20 - 44 3,686 3,538 3,363 3,467 3,750 3,623 3,430 3,479 3,705 3,503 3,219
45 - 64 12,196 11,925 11,147 11,717 12,783 12,056 11,421 11,807 12,662 11,778 10,868
65 - 74 8,011 7,845 7,415 7,875 8,441 8,118 7,688 8,081 8,916 8,497 7,805
75 + 7,415 7,112 6,484 6,947 7,569 7,323 6,853 7,089 7,702 7,054 6,535
Male 18,446 17,738 16,520 17,721 19,176 18,308 17,053 17,887 19,389 17,889 16,548
Female 13,164 12,942 12,129 12,574 13,635 13,109 12,610 12,834 13,882 13,208 12,147
Diabetes 14,409 13,482 12,588 13,888 14,949 14,114 13,373 14,404 15,573 14,264 12,831
Hypertension 9,010 8,803 8,292 8,633 9,514 9,068 8,360 8,257 9,104 8,480 7,715
Glomerulonephritis 2,393 2,377 2,195 2,210 2,367 2,408 2,232 2,315 2,491 2,226 2,022
Cystic kidney 677 690 621 601 664 689 695 819 898 906 796
Other urologic 387 353 366 371 364 342 334 449 443 444 369
Other cause 2,860 3,093 2,869 2,811 2,963 2,900 2,885 3,156 3,253 3,167 2,727
Unknown cause 832 818 752 755 797 735 635 126 146 112 97
Missing cause 1,042 1,064 966 1,026 1,193 1,161 1,149 1,195 1,363 1,498 2,138
All 31,610 30,680 28,649 30,295 32,811 31,417 29,663 30,721 33,271 31,097 28,695

^ Data as of December 31, 2016
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Point prevalent counts of reported ESRD, 2014 Q1 - 2016 Q3
2014^ 2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
0 - 19 7,672 7,643 7,586 7,611 7,636 7,653 7,608 7,608 7,648 7,648 7,640
20 - 44 104,745 105,199 105,212 105,346 105,748 106,166 106,075 106,018 106,177 106,342 106,072
45 - 64 295,489 298,336 300,104 301,969 304,521 307,064 308,751 310,781 313,126 315,141 316,175
65 - 74 151,331 153,695 156,257 158,713 160,858 163,145 165,598 167,974 170,458 173,223 175,198
75 + 107,518 108,650 109,615 110,494 110,895 112,153 113,639 114,906 115,915 117,099 118,328
Male 382,851 387,011 390,286 393,877 397,474 401,682 404,917 408,478 412,528 416,123 418,544
Female 283,823 286,431 288,408 290,176 292,105 294,422 296,678 298,734 300,721 303,256 304,795
Unknown 81 81 80 80 79 77 76 75 75 74 74
Diabetes 252,700 255,362 257,312 259,774 262,197 264,954 267,220 269,891 272,697 275,243 276,487
Hypertension 168,445 170,595 172,378 173,922 175,795 177,798 179,306 180,510 182,044 183,632 184,620
Glomerulonephritis 109,559 110,197 110,704 111,192 111,613 112,264 112,784 113,276 113,791 114,180 114,371
Cystic kidney 31,729 31,989 32,200 32,363 32,561 32,808 33,050 33,453 33,873 34,315 34,648
Other urologic 11,219 11,233 11,312 11,356 11,356 11,399 11,438 11,545 11,596 11,720 11,756
Other cause 57,482 58,180 58,640 58,930 59,215 59,736 60,210 61,002 61,437 62,037 62,174
Unknown cause 25,296 25,345 25,333 25,313 25,271 25,265 25,216 24,650 24,151 23,730 23,287
Missing cause 10,325 10,622 10,895 11,283 11,650 11,957 12,447 12,960 13,735 14,596 16,070
All 666,755 673,523 678,774 684,133 689,658 696,181 701,671 707,287 713,324 719,453 723,413

^ Data as of December 31, 2016
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2014 Q1 - 2016 Q3
2014^ 2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
White 20,207 19,922 18,480 19,668 21,096 20,358 19,327 19,932 21,602 19,971 18,075
Black/African American 8,378 7,900 7,491 7,796 8,559 8,014 7,414 7,803 8,250 7,728 6,799
Native American/Alaska Native 307 276 276 294 304 288 270 264 300 310 265
Asian 1,284 1,169 1,104 1,182 1,292 1,224 1,138 1,196 1,372 1,246 1,115
Pacific Islander 367 340 321 317 353 363 371 361 413 387 366
Other/Unknown * * * * * * . * * * *
No ME Form 1,065 1,069 975 1,036 1,205 1,168 1,143 1,160 1,333 1,451 2,071
Hispanic 4,459 4,097 3,946 4,238 4,558 4,394 4,014 4,266 4,758 4,181 3,673
Non-Hispanic 26,086 25,510 23,726 25,019 27,045 25,853 24,506 25,293 27,180 25,462 22,948
Unknown . * * * * * . * . * *
No ME Form 1,065 1,069 975 1,036 1,205 1,168 1,143 1,160 1,333 1,451 2,071
Hemodialysis (%)1 90.43 89.19 89.94 91.39 90.76 89.74 89.08 90.14 90.36 89.74 89.19
CAPD (%)1 4.13 4.98 4.81 4.37 4.67 5.38 5.77 5.25 4.7 4.82 5.14
CCPD (%)1 5.42 5.81 5.22 4.23 4.54 4.87 5.13 4.6 4.94 5.41 5.65
Other (%)1 0.017 0.017 0.026 0.007 0.032 0.017 0.022 0.01 0.006 0.028 0.019
UnKnown (%)1 . 0.004 . . . . . . . . .
Cathether Only (%)2 61.57 61.43 61.33 61.77 61.89 61.15 61.38 62.76 62.62 62.23 61.52
Catheter w/ maturing AVF (%)2 17.24 16.92 16.21 16.94 17.22 16.62 15.73 15.77 16.11 16.61 15.85
Catheter w/ maturing AVG (%)2 1.86 1.81 1.65 1.77 1.7 1.8 1.82 1.71 1.59 1.64 1.58
AVF (%)2 16.53 16.61 17.48 16.45 16.16 17.24 17.77 16.55 16.62 16.3 17.35
AVG (%)2 2.61 3.03 3.06 2.86 2.79 3.01 3.11 3.01 2.84 3.05 3.38
Other(%)2 0.15 0.14 0.22 0.17 0.2 0.15 0.14 0.15 0.14 0.088 0.16
Unknown(%)2 0.048 0.066 0.053 0.038 0.046 0.034 0.052 0.054 0.074 0.077 0.15
Pre-ESRD EPO(% Yes)3 14.29 14.47 14.43 14.1 13.5 13.6 13.67 13.23 13.29 13.1 13.13
Pre-ESRD Nephrology(% Yes)3 70.67 71.73 72.62 72.05 72.74 73.98 74.54 73.92 74.47 75.49 76.33
Mean Serum Albumin(g/dL)4 3.22 3.24 3.22 3.18 3.16 3.2 3.23 3.19 3.16 3.2 3.22
Mean Serum Creatinine(mg/dL)4 6.61 6.56 6.55 6.54 6.57 6.48 6.47 6.47 6.45 6.43 6.46
Mean Hemoglobin(g/dL)4 9.52 9.5 9.55 9.43 9.4 9.44 9.44 9.36 9.34 9.37 9.39
All 31,610 30,680 28,649 30,295 32,811 31,417 29,663 30,721 33,271 31,097 28,695
All with ME Form 30,545 29,611 27,674 29,259 31,606 30,249 28,520 29,561 31,938 29,646 26,624
Dialysis Pts with ME Form 29,907 28,973 27,020 28,587 31,045 29,625 27,878 28,981 31,434 29,080 26,145
Hemodialysis Pts w/ ME Form 27,045 25,841 24,303 26,126 28,176 26,584 24,835 26,123 28,403 26,097 23,320

^ Data as of December 31, 2016.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.